GO
Loading...

Perrigo Co

More

  • U.S. stock index futures ticked lower on Monday, ahead of the Federal Reserve meeting and another heavy week for second quarter earnings.

  • Ben Bernanke the M&A banker? Monday, 29 Jul 2013 | 8:57 AM ET

    The Federal Reserve's taper talk may have rattled the financial markets but it has had one notable beneficiary: Mergers and acquisitions.

  • US drugmaker Perrigo to buy Ireland's Elan Monday, 29 Jul 2013 | 2:43 AM ET

    U.S. generic drugmaker Perrigo agreed to buy fellow drug company Elan for $8.6 billion on Monday in a deal that will hand it royalty rights from a blockbuster treatment and tax savings from being domiciled in Ireland.

  • Perrigo CEO Joe Papa discusses the biotech industry, the state of the consumer and why Mucinex is going to be a big winner for his company.

  • Cramer’s Trend Watch: Store Brands Thursday, 9 May 2013 | 6:14 PM ET

    As the economy stalled, many people opted for store brand medicines. But as the economy improves, will the trend reverse?

  • Greenberg: It's the Stocks You Don't Own That Matter Thursday, 31 Jan 2013 | 8:17 AM ET

    The Forensic Accounting ETF launches today. The fund spotlights a concept that is often woefully overlooked.

  • Perrigo gets FDA OK to sell nicotine lozenges Wednesday, 10 Oct 2012 | 1:56 PM ET

    ALLEGAN, Mich.-- Perrigo Co., which makes store-brand over-the-counter drugs and infant formulas, said Wednesday that it received approval from the U.S. Food and Drug Administration to market an over-the-counter nicotine product similar to Nicorette mini lozenges.

  • *Receives FDA approval to market mini nicotine lozenges.

  • You’ve heard about all those big stocks that you should buy, but the pros say there are plenty of mid-size names that belong on your radar too.

  • Perrigo CEO on Earnings Beat Wednesday, 8 Feb 2012 | 7:39 PM ET

    Perrigo CEO Joseph Papa appeared on Wednesday's "Mad Money."

  • Perrigo CEO on Earnings Beat     Wednesday, 8 Feb 2012 | 6:45 PM ET

    Perrigo CEO, Joseph Papa discusses his company's 11% Q2 profit rise, and its outlook on growth, with Mad Money's Jim Cramer.

  • Perrigo's CEO on Earnings     Thursday, 27 Oct 2011 | 2:35 PM ET

    A breakdown of better-than-expected earnings from the generic drug maker, with Joseph Papa, Perrigo CEO.

  • Cramer: Do Your Homework Wednesday, 19 Oct 2011 | 6:15 PM ET

    A lot of people aren’t doing their homework and those people are losing money.

  • How Investors Can Diversify When Markets Move Together Friday, 14 Oct 2011 | 12:46 PM ET

    When it comes to combating financial markets that all seem to move in unison, the options are getting so limited that some are questioning whether stock picking is a dying art.

  • Stock Picking by the Individual Investor Isn't Dead Thursday, 13 Oct 2011 | 3:34 PM ET

    Cramer and his researcher, Nicole Urken, discuss why homework—particularly during earnings season—remains important to recognizing the stock winners of the coming years.

  • Perrigo CEO: Why Business is Growing Tuesday, 27 Sep 2011 | 6:42 PM ET

    Joseph Papa sits down with Cramer and explains why things are looking good for the private label drug maker.

  • Perrigo CEO Talks China Biz     Tuesday, 27 Sep 2011 | 6:15 PM ET

    Mad Money host Jim Cramer takes a look at Perrigo, which develops, manufactures and distributes private label goods to retailers. Joseph Papa, chairman, president & CEO of Perrigo, weighs in. "Our products are popular in both bull and bear markets," he says.

  • Perrigo Rising     Wednesday, 7 Sep 2011 | 1:35 PM ET

    Does Perrigo still have room to run? Shares of the recession-resistant business are up about 45 percent and among the top ten S&P 400 midcap stocks, with Linda Bolton Weiser, Caris & Company managing director.

  • Cramer: Trading the Euro Zone Debt Crisis Tuesday, 16 Aug 2011 | 6:28 PM ET

    The “Mad Money” host explains why Europe’s problems trump good news out of the US.

  • The 7 Things Cramer's Watching Tuesday Monday, 15 Aug 2011 | 6:45 PM ET

    There's a lot going on in this volatile market, but Cramer thinks it's important to monitor the following things in particular.

Most Popular Video

Thursday, 17 Apr 2014 | 1:03 PM ET

Dissecting the current market action amid geopolitical concerns, with Kenny Polcari, O'Neil Securities, and CNBC's Dominic Chu.

Thursday, 17 Apr 2014 | 12:06 PM ET

Discussing the case for stocks, with Ed Yardeni, president and chief investment strategist of Yardeni Research. He thinks the market had an "internal correction."

Thursday, 17 Apr 2014 | 1:00 PM ET

Secretary of State John Kerry comments after a meeting in Geneva with Russian Foreign Minister Sergey Lavrov and representatives of the EU and Ukraine.